190 related articles for article (PubMed ID: 34389986)
1. Congenital disorders of glycosylation with defective fucosylation.
Hüllen A; Falkenstein K; Weigel C; Huidekoper H; Naumann-Bartsch N; Spenger J; Feichtinger RG; Schaefers J; Frenz S; Kotlarz D; Momen T; Khoshnevisan R; Riedhammer KM; Santer R; Herget T; Rennings A; Lefeber DJ; Mayr JA; Thiel C; Wortmann SB
J Inherit Metab Dis; 2021 Nov; 44(6):1441-1452. PubMed ID: 34389986
[TBL] [Abstract][Full Text] [Related]
2. D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG).
Starosta RT; Lee AJ; Toolan ER; He M; Wongkittichote P; Daniel EJP; Radenkovic S; Budhraja R; Pandey A; Sharma J; Morava E; Nguyen H; Dickson PI
Mol Genet Metab; 2024 Jun; 142(2):108488. PubMed ID: 38735264
[TBL] [Abstract][Full Text] [Related]
3. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency.
Lübke T; Marquardt T; Etzioni A; Hartmann E; von Figura K; Körner C
Nat Genet; 2001 May; 28(1):73-6. PubMed ID: 11326280
[TBL] [Abstract][Full Text] [Related]
4. A combination of two novels homozygous FCSK variants cause disorder of glycosylation with defective fucosylation: New patient and literature review.
Manoochehri J; Kamal N; Khamirani HJ; Zoghi S; Haghighi MF; Goodarzi HR; Bagher Tabei SM
Eur J Med Genet; 2022 Aug; 65(8):104535. PubMed ID: 35718084
[TBL] [Abstract][Full Text] [Related]
5. A spoonful of L-fucose-an efficient therapy for GFUS-CDG, a new glycosylation disorder.
Feichtinger RG; Hüllen A; Koller A; Kotzot D; Grote V; Rapp E; Hofbauer P; Brugger K; Thiel C; Mayr JA; Wortmann SB
EMBO Mol Med; 2021 Sep; 13(9):e14332. PubMed ID: 34468083
[TBL] [Abstract][Full Text] [Related]
6. Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability.
Knapp KM; Luu R; Baerenfaenger M; Zijlstra F; Wessels HJCT; Jenkins D; Lefeber DJ; Neas K; Bicknell LS
J Hum Genet; 2020 Sep; 65(9):743-750. PubMed ID: 32313197
[TBL] [Abstract][Full Text] [Related]
7. Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1-congenital disorder of glycosylation) and response to l-fucose therapy: Insights from two new families and review of the literature.
Tahata S; Raymond K; Quade M; Barnes S; Boyer S; League S; Kumanovics A; Abraham R; Jacob E; Menon P; Morava E
Am J Med Genet A; 2022 Jul; 188(7):2005-2018. PubMed ID: 35338746
[TBL] [Abstract][Full Text] [Related]
8. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.
Vals MA; Ashikov A; Ilves P; Loorits D; Zeng Q; Barone R; Huijben K; Sykut-Cegielska J; Diogo L; Elias AF; Greenwood RS; Grunewald S; van Hasselt PM; van de Kamp JM; Mancini G; Okninska A; Pajusalu S; Rudd PM; Rustad CF; Salvarinova R; de Vries BBA; Wolf NI; ; Ng BG; Freeze HH; Lefeber DJ; Õunap K
J Inherit Metab Dis; 2019 May; 42(3):553-564. PubMed ID: 30746764
[TBL] [Abstract][Full Text] [Related]
9. Congenital disorder of glycosylation with defective fucosylation 2 (FCSK gene defect): The third report in the literature with a mild phenotype.
Al Tuwaijri A; Alyafee Y; Umair M; Alsubait A; Alharbi M; AlEidi H; Ballow M; Aldrees M; Alam Q; Al Abdulrahman A; Alrifai MT; Alfadhel M
Mol Genet Genomic Med; 2023 Apr; 11(4):e2117. PubMed ID: 36426412
[TBL] [Abstract][Full Text] [Related]
10. Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation.
Ng BG; Xu G; Chandy N; Steyermark J; Shinde DN; Radtke K; Raymond K; Lebrilla CB; AlAsmari A; Suchy SF; Powis Z; Faqeih EA; Berry SA; Kronn DF; Freeze HH
Am J Hum Genet; 2018 Jan; 102(1):188-195. PubMed ID: 29304374
[TBL] [Abstract][Full Text] [Related]
11. CDG Therapies: From Bench to Bedside.
Brasil S; Pascoal C; Francisco R; Marques-da-Silva D; Andreotti G; Videira PA; Morava E; Jaeken J; Dos Reis Ferreira V
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702557
[TBL] [Abstract][Full Text] [Related]
12. Congenital disorders of glycosylation: The Saudi experience.
Alsubhi S; Alhashem A; Faqeih E; Alfadhel M; Alfaifi A; Altuwaijri W; Alsahli S; Aldhalaan H; Alkuraya FS; Hundallah K; Mahmoud A; Alasmari A; Mutairi FA; Abduraouf H; AlRasheed L; Alshahwan S; Tabarki B
Am J Med Genet A; 2017 Oct; 173(10):2614-2621. PubMed ID: 28742265
[TBL] [Abstract][Full Text] [Related]
13. SLC35A2-CDG: novel variants with two ends of the spectrum.
Kasapkara ÇS; Ceylan AC; Özyürek H; Karakaya Molla G; Civelek Ürey B; Kıreker Köylü O; Küçükçongar Yavaş A; Sönmez FM
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1185-1189. PubMed ID: 34161696
[TBL] [Abstract][Full Text] [Related]
14. Expanding the molecular and clinical phenotypes of FUT8-CDG.
Ng BG; Dastsooz H; Silawi M; Habibzadeh P; Jahan SB; Fard MAF; Halliday BJ; Raymond K; Ruzhnikov MRZ; Tabatabaei Z; Taghipour-Sheshdeh A; Brimble E; Robertson SP; Faghihi MA; Freeze HH
J Inherit Metab Dis; 2020 Jul; 43(4):871-879. PubMed ID: 32049367
[TBL] [Abstract][Full Text] [Related]
15. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
16. Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc.
Ishikawa HO; Higashi S; Ayukawa T; Sasamura T; Kitagawa M; Harigaya K; Aoki K; Ishida N; Sanai Y; Matsuno K
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18532-7. PubMed ID: 16344471
[TBL] [Abstract][Full Text] [Related]
17. SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.
Ng BG; Sosicka P; Agadi S; Almannai M; Bacino CA; Barone R; Botto LD; Burton JE; Carlston C; Chung BH; Cohen JS; Coman D; Dipple KM; Dorrani N; Dobyns WB; Elias AF; Epstein L; Gahl WA; Garozzo D; Hammer TB; Haven J; Héron D; Herzog M; Hoganson GE; Hunter JM; Jain M; Juusola J; Lakhani S; Lee H; Lee J; Lewis K; Longo N; Lourenço CM; Mak CCY; McKnight D; Mendelsohn BA; Mignot C; Mirzaa G; Mitchell W; Muhle H; Nelson SF; Olczak M; Palmer CGS; Partikian A; Patterson MC; Pierson TM; Quinonez SC; Regan BM; Ross ME; Guillen Sacoto MJ; Scaglia F; Scheffer IE; Segal D; Singhal NS; Striano P; Sturiale L; Symonds JD; Tang S; Vilain E; Willis M; Wolfe LA; Yang H; Yano S; Powis Z; Suchy SF; Rosenfeld JA; Edmondson AC; Grunewald S; Freeze HH
Hum Mutat; 2019 Jul; 40(7):908-925. PubMed ID: 30817854
[TBL] [Abstract][Full Text] [Related]
18. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
19. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
20. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.
Westenfield K; Sarafoglou K; Speltz LC; Pierpont EI; Steyermark J; Nascene D; Bower M; Pierpont ME
BMC Med Genet; 2018 Jun; 19(1):100. PubMed ID: 29907092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
